In the SELUTION DeNovo HBR substudy, a sirolimus-eluting balloon strategy with provisional stenting showed numerically lower rates of target vessel failure, major bleeding, and net adverse clinical events than systematic DES implantation at 1 year.
t.co/6LxdEvszIC
#cardiosky